The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Primary Cutaneous T-Cell Lymphoma: Review and Current Concepts
Abstract
PURPOSE: Primary cutaneous T-cell lymphomas (CTCLs) encompass a wide variety of lymphomas that are characterized by the localization of the malignant lymphocytes to the skin at presentation. Advances in molecular biologic techniques, including immunophenotyping and gene rearrangement studies to determine clonality, have led to more frequent diagnosis of CTCL as well as more consistent subclassification of these entities. However, there continues to be confusion in the classification, prognosis, and management of patients with CTCL. The purpose of this review is to present a summary of the diagnosis, prognosis, and treatment of CTCL, with specific emphasis on mycosis fungoides (MF) and Sézary syndrome (SS). We also present a detailed discussion of the entities that make up the differential diagnosis of CTCL. DESIGN: We reviewed the medical literature on CTCL and other diseases that make up the differential diagnosis of CTCL. Results and CONCLUSION: MF and SS are the most common forms of CTCL. The etiology of this disease is still unknown. Patients may go for months to years with skin abnormalities before being diagnosed. MF/SS is an indolent disease and patients with T1 disease have a normal life expectancy. Patients who undergo transformation to large-cell lymphoma (8% to 23% of patients) have a poor prognosis, with mean survival ranging from 2 to 19 months. Treatment for MF/SS continues to be palliative. There are many new therapies that are currently being investigated in clinical trials, and the DAB 389 IL-2 fusion protein was recently approved for the treatment of refractory MF/SS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, N., Jaffe, E., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., De Wolf- Peeters, C., Falini, B., & Gatter, K. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,327
Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043
Maloney, D. G., Grillo-López, A. J., White, C. A., Bodkin, D., Schilder, R. J., Neidhart, J. A., Janakiraman, N., Foon, K. A., Liles, T.-M., Dallaire, B. K., et al. (1997) · Blood · doi:10.1182/blood.v90.6.2188 · Cited by 1,733
Willemze, R., Kerl, H., Sterry, W., Berti, E., Cerroni, L., Chimenti, M. S., Díaz-Pérez, J. L., Geerts, M., Goos, M., Knobler, R., et al. (1997) · PubMed · doi:10.1182/blood.v90.1.354 · Cited by 1,270
Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy
Edelson, R., Berger, C., Gasparro, F., Jegasothy, B., Heald, P., Wintroub, B., Vonderheid, E., Knobler, R., Wolff, K., Plewig, G., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702053160603 · Cited by 1,199
Molecular Analysis of the T(14;18) Chromosomal Translocation in Malignant Lymphomas
Weiss, L. M., Warnke, R. A., Sklar, J., & Cleary, M. L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711053171904 · Cited by 679
Kaye, F. J., Bunn, P. A., Steinberg, S. M., Stocker, J. L., Ihde, D. C., Fischmann, A. B., Glatstein, E. J., Schechter, G. P., Phelps, R. M., Foss, F. M., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212603 · Cited by 487
Kristiansen, K., Hagen, S., Kollevold, T., TORVIK, A., Holme, I., Stat, M. A., Nesbakken, R., Hatlevoll, R., Lindgren, M., Brun, A., et al. (1981) · Cancer · doi:10.1002/1097-0142(19810215)47:4<698::aid-cncr2820470413>3.0.co;2-z · Cited by 424
Infection by Borrelia burgdorferi and cutaneous B‐cell lymphoma
Cerroni, L., Zöchling, N., Pütz, B., & Kerl, H. (1997) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.1997.tb01318.x · Cited by 415
Weiss, L. M., Hu, E., Wood, G. S., Moulds, C., Cleary, M. L., Warnke, R., & Sklar, J. (1985) · New England Journal of Medicine · doi:10.1056/nejm198508293130903 · Cited by 339
Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis
Diamandidou, E., Colome-Grimmer, M., Fayad, L., Duvic, M., & Kurzrock, R. (1998) · Blood · doi:10.1182/blood.v92.4.1150 · Cited by 334
Prognosis in cutaneous T-cell lymphoma by skin stage: Long-term survival in 489 patients
Zackheim, H. S., Amin, S., Kashani-Sabet, M., & McMillan, A. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70491-3 · Cited by 294
Mycosis Fungoides in the United States: Increasing Incidence and Descriptive Epidemiology
Weinstock, M. A. (1988) · JAMA · doi:10.1001/jama.1988.03410010050033 · Cited by 285
Mycosis fungoides and Sezary syndrome [see comments]
Diamandidou, E., Cohen, P., & Kurzrock, R. (1996) · Blood · doi:10.1182/blood.v88.7.2385.bloodjournal8872385 · Cited by 273
Jackow, C. M., Cather, J. C., Hearne, V., Asano, A. T., Musser, J. M., & Duvic, M. (1997) · Blood · doi:10.1182/blood.v89.1.32 · Cited by 270
Dierlamm, J., Pittaluga, S., Włodarska, I., Stul, M. S., Thomas, J., Boogaerts, M. A., Michaux, L., Driessen, A. L. C., Mecucci, C., & Cassiman, J. (1996) · Blood · doi:10.1182/blood.v87.1.299.299 · Cited by 268
Histopathologic Staging at Initial Diagnosis of Mycosis Fungoides and the Sézary Syndrome
Sausville, E. A., Eddy, J. L., Makuch, R. W., Fischmann, A. B., Schechter, G. P., Matthews, M., GLATSTEIN, E. J., Ihde, D. C., Kaye, F., Veach, S. R., et al. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-5-372 · Cited by 268
Lundin, J., Osterborg, A., Brittinger, G., Crowther, D., Dombret, H., Engert, A., Epenetos, A., Gisselbrecht, C., Huhn, D., Jaeger, U., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3257 · Cited by 255
Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice.
Rich, B. E., Campos-Torres, J., Tepper, R. I., Moreadith, R. W., & Leder, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.305 · Cited by 244
Cerroni, L., Signoretti, S., Höfler, G., Annessi, G., Pütz, B., Lackinger, E., Metze, D., Giannetti, A., & Kerl, H. (1997) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199711000-00005 · Cited by 239
Deleted HTLV-I Provirus in Blood and Cutaneous Lesions of Patients with Mycosis Fungoides
Hall, W. W., Liu, C. R., Schneewind, O., Takahashi, H., Kaplan, M. H., Röupe, G., & Vahlne, A. (1991) · Science · doi:10.1126/science.1857968 · Cited by 183
Hoppe, R. T., Medeiros, L. J., Warnke, R. A., & Wood, G. S. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)90067-5 · Cited by 182
Sun, W. H., Pabon, C., Alsayed, Y., Huang, P. P., Jandeska, S., Uddin, S., Platanias, L. C., & Rosen, S. T. (1998) · Blood · doi:10.1182/blood.v91.2.570 · Cited by 169
Self-citationPhase II Study of Recombinant Human Interferon Gamma for Treatment of Cutaneous T-Cell Lymphoma
Kaplan, E. H., Rosen, S. T., Norris, D. B., Roenigk, H. H., Saks, S. R., & Bunn, P. A. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.3.208 · Cited by 168
Self-citationCutaneous immunocytomas: a clinicopathologic study of 26 cases
Rijlaarsdam, J. U., van der Putte, S. C. J., Berti, E., Kerl, H., RIEGER, E., Toonstra, J., Geerts, M. L., Meijer, C. J. L. M., & Willemze, R. (1993) · Histopathology · doi:10.1111/j.1365-2559.1993.tb00469.x · Cited by 165
Muche, J. M., Lukowsky, A., Asadullah, K., Gellrich, S., & Sterry, W. (1997) · Blood · doi:10.1182/blood.v90.4.1636 · Cited by 165
Interleukin-7 is a growth factor for Sézary lymphoma cells.
Dalloul, A., Laroche, L., Bagot, M., Mossalayi, M. D., Fourcade, C., Thacker, D. J., Hogge, D. E., Merle-Béral, H., Debré, P., & Schmitt, C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115920 · Cited by 162
Lambert, W. C., & Everett, M. A. (1981) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(81)70100-2 · Cited by 159
Interferon in the Treatment of Cutaneous T-cell Lymphoma
Olsen, E. A., & Bunn, P. A. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30060-1 · Cited by 144
Isotretinoin and Cutaneous Helper T-Cell Lymphoma (Mycosis Fungoides)
Kessler, J. F., Jones, S. E., Levine, N., Lynch, P. J., Booth, A. R., & Meyskens, F. L. (1987) · Archives of Dermatology · doi:10.1001/archderm.1987.01660260071016 · Cited by 137
Antitumor activity of DAB389 IL-2 fusion toxin in mycosis fungoides
Saleh, M. N., LeMaistre, C. F., Kuzel, T. M., Foss, F. M., Platanias, L. C., Schwartz, G. N., Ratain, M. J., Rook, A. H., Freytes, C. O., Craig, F. E., et al. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70403-7 · Cited by 137
Self-citationMycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy.
Kuzel, T. M., Roenigk, H. H., & Rosen, S. T. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.7.1298 · Cited by 136
Self-citationThangavelu, M., Finn, W. G., Yelavarthi, K. K., Roenigk, H. H., Samuelson, E., Peterson, L. C., Kuzel, T. M., & Rosen, S. T. (1997) · Blood · doi:10.1182/blood.v89.9.3371 · Cited by 126
Self-citationTopical mechiorethamine therapy for early stage mycosis fungoides
Ramsay, D. L., Halperin, P. S., & Zeleniuch‐Jacquotte, A. (1988) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(88)70223-6 · Cited by 118
MALT and SALT: the clue to cutaneous B-cell lymphoproliferative disease
Slater, D. N. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08560.x · Cited by 109
The Immunopemthogenesis of Cutaneous T-cell Lymphoma
Rook, A. H., & HEALD, P. W. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30054-6 · Cited by 106
The Immunopathogenesis of Cutaneous T-Cell Lymphoma
Rook, A. H. (1993) · Archives of Dermatology · doi:10.1001/archderm.1993.01680250098016 · Cited by 98
Prognostic Clinicopathologic Factors in Cutaneous T-cell Lymphoma
Marti, R. (1991) · Archives of Dermatology · doi:10.1001/archderm.1991.01680090075007 · Cited by 96
Fox, F. E., Niu, Z., Tobia, A. J., & Rook, A. H. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00278.x · Cited by 91
Identification of Secretory Immunoglobulin A in Human Sweat and Sweat Glands
Okada, T., Konishi, H., Ito, M., Nagura, H., & Asai, J. (1988) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12560807 · Cited by 89
Extracorporeal Photopheresis in Sézary Syndrome
Fraser-Andrews, E. A., Seed, P. T., Whittaker, S. J., & Russell‐Jones, R. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.8.1001 · Cited by 89
Dréno, B., Claudy, A., Meynadier, J., Verret, J. L., Souteyrand, P., Ortonne, J. ‐., Kalis, B., Godefroy, W., Beerblock, K., & Thill, L. (1991) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1991.tb14772.x · Cited by 87
Bakels, V., Oostveen, J. W. V., van der Putte, S. C. J., Meijer, C. J. L. M., & Willemze, R. (1997) · Europe PMC (PubMed Central) · Cited by 86
Photochemotherapy for Mycosis Fungoides
Lowe, N. J. (1979) · Archives of Dermatology · doi:10.1001/archderm.1979.04010010022007 · Cited by 79
Tensen, C. P., Vermeer, M. H., van der Stoop, P. M., van Beek, P., Scheper, R. J., Boorsma, D. M., & Willemze, R. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00263.x · Cited by 78
Weinstock, M. A., & Horm, J. W. (1988) · Cancer · Cited by 78
Ackerman, A. B. (1996) · Archives of Dermatology · doi:10.1001/archderm.1996.03890290096013 · Cited by 72
Burg, G., Dummer, R., Nestle, F. O., Doebbeling, U., & Haeffner, A. (1996) · Archives of Dermatology · doi:10.1001/archderm.1996.03890290101014 · Cited by 65
High-Dose Recombinant Interleukin-2 in Advanced Cutaneous T-Cell Lymphoma
Marolleau, J. P. (1995) · Archives of Dermatology · doi:10.1001/archderm.1995.01690170076011 · Cited by 62
T‐cell‐rich B‐cell lymphoma presenting in skin
Sander, C. A., Kaudewitz, P., Kutzner, H., Simon, M., Schirren, C. G., Sioutos, N., Cossman, J., Plewig, G., Kind, P., & Jaffe, E. S. (1996) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.1996.tb01282.x · Cited by 55
DiCaudo, D. J., Perniciaro, C., Worrell, J., White, J. W., & Cockerell, C. J. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90836-1 · Cited by 50
Parapsoriasis and mycosis fungoides: The Northwestern University experience, 1970 to 1985
Lazar, A. P., Caro, W. A., Roenigk, H. H., & Pinski, K. S. (1989) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(89)70277-2 · Cited by 46
Immunoreactivity for bcl‐2 protein in cutaneous lymphomas and lymphoid hyperplasias*
Triscott, J. A., Ritter, J. H., Swanson, P. E., et al. (1995) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.1995.tb00732.x · Cited by 41
Guitart, J., & Kaul, K. L. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.2.158 · Cited by 39
Self-citationThe Potential Therapeutic Role of Interleukin‐12 in Cutaneous T‐Cell Lymphomaa
Rook, A. H., RUBIN, M., Fox, F. E., Niu, Z., Cassin, M., Vowels, B. R., Gottleib, S. L., Vonderheid, E. C., Lessin, S. R., & TRINCHIERF, G. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb52680.x · Cited by 38
Acrocyanosis Induced by Interferon α2a
Campo-Voegeli, A., Estrach, T., Marti, R. M., Corominas, N., Tuset, M., & Mascaró, J. M. (1998) · Dermatology · doi:10.1159/000017917 · Cited by 37
Molin, L., Thomsen, K., VOLDEN, G., Jensen, P., KNUDSEN, E. A., Nyfors, A., & Schmidt, H. (1987) · Acta Dermato Venereologica · doi:10.2340/0001555567179182 · Cited by 32
Luger, T. A., Schwarz, T., Krutmann, J., K�ck, A., Urbanski, A., & Kirnbauer, R. (2015) · Current problems in dermatology · doi:10.1159/000418075 · Cited by 30
Vandenberghe, E. (1994) · Blood Reviews · doi:10.1016/s0268-960x(05)80011-6 · Cited by 22
The molecular biology of B-cell lymphoma: Clinicopathologic implications
Kluin, P. M., & van Krieken, J. H. (1991) · Annals of Hematology · doi:10.1007/bf01702921 · Cited by 17
Cutaneous Pseudolymphomas: Immunophenotypical and Immunogenotypical Studies
Wechsler, J., Bagot, M., Henni, T., & Gaulard, P. (2015) · Current problems in dermatology · doi:10.1159/000418090 · Cited by 17
Cutaneous lymphomas other than mycosis fungoides.
Joly, P., Thomine, E., & Lauret, P. (1994) · PubMed · Cited by 13
Cited by
Piekarz, R. L., Robey, R., Sandor, V., Bakke, S., Wilson, W. H., Dahmoush, L., Kingma, D. M., Turner, M. L., Altemus, R., & Bates, S. E. (2001) · Blood · doi:10.1182/blood.v98.9.2865 · Cited by 445
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome
Trautinger, F., Knobler, R., Willemze, R., Peris, K., Stadler, R., Laroche, L., D’Incan, M., Ranki, A., Pimpinelli, N., Ortiz-Romero, P., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.025 · Cited by 416
VanderMolen, K. M., McCulloch, W., Pearce, C. J., & Oberlies, N. H. (2011) · The Journal of Antibiotics · doi:10.1038/ja.2011.35 · Cited by 333
Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell Lymphoma
Mann, B. S., Johnson, J. R., He, K., Sridhara, R., Abraham, S., Booth, B. P., Verbois, L., Morse, D. E., Jee, J. M., Pope, S., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2672 · Cited by 262
Photopheresis in the treatment of cutaneous T-cell lymphoma: current status
Zic, J. A. (2012) · Current Opinion in Oncology · doi:10.1097/01.cco.0000410158.56500.c4 · Cited by 25
Metadata
- Authors
- Siegel, R. S., Pandolfino, T., Guitart, J., Rosen, S., & Kuzel, T. M.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-08-15
- Volume
- 18
- Issue
- 15
- Pages
- 2908-2925
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1901742546
- Cited by
- 308
- References
- 62
- FWCI
- 26.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.